A

Arrowhead Pharmaceuticals

ARWR

27.410
USD
-1.16
(-4.06%)
مفتوح الان
حجم التداول
3,613
الربح لكل سهم
0
العائد الربحي
0
P/E
-4
حجم السوق
2,536,031,590
أصول ذات صلة
A
ABEO
-0.10000
(-2.04%)
4.80000 USD
A
ABUS
0.03500
(0.93%)
3.80500 USD
A
ALNY
31.19
(13.13%)
268.66 USD
B
BCRX
-0.19000
(-2.61%)
7.10000 USD
C
CRSP
-2.450
(-4.28%)
54.840 USD
E
EDIT
-0.28500
(-5.26%)
5.13500 USD
N
NTLA
-1.100
(-4.19%)
25.130 USD
REGN
13.14
(1.22%)
1,091.19 USD
S
SGMO
-0.09690
(-12.11%)
0.70340 USD
الأخبار المقالات

العنوان: Arrowhead Pharmaceuticals

القطاع: Healthcare
الصناعة: Biotechnology
Arrowhead Pharmaceuticals Inc is an American biotechnology company. Its main target is the development of medicine to treat diseases with a genetic origin, characterized by the overproduction of one or more proteins. Its medical solutions are aimed at the genes that trigger the diseases. Its portfolio includes drugs targeting hepatitis B, Alpha-1 Antitrypsin Deficiency, thrombosis and angioedema, clear-cell and renal cell carcinoma, and cardiovascular disease.